Biotechnology in Europe: 2006 Comparative study
![]()
By Critical I comparative study for EuropaBio
Publisher: Critial I Thinking Allowed Colin Sanders Innovation Centre
Number Of Pages: 42
Publication Date: 2006
Binding: pdf
This is the second report Critical I has produced that compares the biotechnology sectors across some eighteen European nations and the USA. As part of its ongoing survey work, Critical I has looked in depth at the biotechnology sectors of four European nations – France, Germany, Switzerland, and the UK – and at that of the USA. For these countries, and also for the 2003 data presented here for the Scandinavian nations of Denmark, Finland, Norway and Sweden, and for Ireland, the information has been gathered and validated according to the approach outlined in the Methodology Appendix. In addition, Critical I has undertaken some preliminary survey work on nine additional European nations – Austria, Belgium, Estonia, Greece, Hungary, Italy, The Netherlands, Portugal, and Spain. We have also updated our records for the four Scandinavian nations and Ireland. For these thirteen nations, we have used available primary information sources to assess on an individual company basis within the definitions used in this survey. We have worked closely with the bioindustry organisations in some of these countries, notably with Flanders Bio in Belgium, Bionova in Greece, Assobiotec in Italy, NIABA in the Netherlands, SwedenBio in Sweden, and Genoma Espagne in Spain. We have also been able to obtain information on metrics such as numbers of employees, research spending, number of R
上一篇：Life Sciences And Biotechnology A Strategy For Europe European Commission 下一篇：Evo-Devo Evolution of animal design – Lecture 4 (Hox Genes)
